Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIPIZIDE vs GLOFITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLIPIZIDE vs GLOFITAMAB: Safety Overview

Metric GLIPIZIDE GLOFITAMAB
Total FAERS Reports 4,099 1,116
Deaths Reported 552 315
Death Rate 13.5% 28.2%
Hospitalizations 1,030 492
Average Patient Age 63.4 yrs 62.5 yrs
% Female Patients 51.3% 53.2%
FDA Approval Date Apr 26, 1994 N/A
Manufacturer Bryant Ranch Prepack Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A